Avanafil long-term phase 3 trial in erectile dysfunction meets primary endpoints
VIVUS, Inc. today announced that positive results from a pivotal phase 3 open-label clinical trial evaluating long-term safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction were presented at the 2011 Annual Meeting of the American Urological Association in Washington, D.C.
Sleep Apnea Information – Snoring Treatments
